GHK-Cu is the peptide most directly aimed at collagen synthesis and skin firmness
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
AOD-9604 contains the hGH 177191 sequence with an added tyrosine at the N-terminus (for stabilisation), whereas HGH Fragment 176-191 is one amino acid shorter and unstabilised
Hydrogen Bonding is good at bonding any alcohol and water to make them more soluble, but sometimes, longer chains of alcohols will not be able to dissolve in large amounts of water
BPC-157 10mg Synthetic Pentadecapeptide Research Compound BPC-157 (Body Protection Compound 157) is a synthetic 15-amino acid peptide derived from a protective protein found in human gastric juice
Barrett's esophagus Barrett's esophagus, which is linked to chronic heartburn, can turn into cancer of the esophagus
